CRVS EBITDA
Corvus Pharmaceuticals Inc · EBITDA
CRVS EBITDA
Latest reported-$51.52Mperiod ending
CRVS TTM EBITDA ($3.98M → -$51.52M)
TTM EBITDA
High-resolution chart · PNG
CRVS ebitda history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | EBITDA (USD) |
|---|---|
| -51,519,000 | |
| -42,272,000 | |
| -15,178,000 | |
| -14,976,000 | |
| -45,043,000 | |
| -41,315,000 | |
| -62,208,000 | |
| -56,740,000 | |
| -22,514,000 | |
| -24,740,000 | |
| -26,878,000 | |
| -29,975,000 | |
| -38,742,000 | |
| -40,546,000 | |
| -40,940,000 | |
| -40,353,000 | |
| -36,170,000 | |
| -39,529,000 | |
| -42,665,000 | |
| -43,267,000 | |
| -42,411,000 | |
| -41,389,000 | |
| -43,128,000 | |
| -44,646,000 | |
| -46,275,000 | |
| -49,077,000 | |
| -48,111,000 | |
| -47,847,000 | |
| -47,441,000 | |
| -46,069,000 | |
| -48,375,000 | |
| -49,354,000 | |
| -51,166,000 | |
| -54,094,000 | |
| -55,682,000 | |
| -54,777,000 | |
| -52,361,000 | |
| -46,076,000 | |
| -36,383,000 | |
| -13,765,000 | |
| -6,513,000 | |
| -129,000 | |
| 3,978,000 | |
| -7,421,364 |